Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. trimmed its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 61.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,112 shares of the company’s stock after selling 43,694 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Oscar Health were worth $364,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC raised its stake in shares of Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after buying an additional 844 shares in the last quarter. KBC Group NV raised its stake in shares of Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after buying an additional 1,328 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Oscar Health by 9.2% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company’s stock worth $561,000 after buying an additional 2,236 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in shares of Oscar Health by 28.2% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 21,968 shares of the company’s stock worth $295,000 after buying an additional 4,838 shares in the last quarter. Finally, Rhumbline Advisers raised its stake in shares of Oscar Health by 2.4% during the 4th quarter. Rhumbline Advisers now owns 271,227 shares of the company’s stock worth $3,645,000 after buying an additional 6,483 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Jefferies Financial Group initiated coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $21.56.

Oscar Health Stock Performance

NYSE OSCR opened at $15.99 on Friday. Oscar Health, Inc. has a 1-year low of $12.43 and a 1-year high of $23.79. The company has a market capitalization of $4.01 billion, a P/E ratio of -799.25 and a beta of 1.75. The business has a 50 day moving average price of $15.12 and a 200 day moving average price of $16.52. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Sell-side analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.